William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
Autolus Announces Pricing of Initial Public Offering
-
Autolus Announces Pricing of Initial Public Offering
-
Oil-Dri Announces Appointment of Ellen-Blair Chube as Board Member and Declaration of Increased Quarterly Dividends
-
The 2018 Deal Award Winners Announced
-
Kezar Life Sciences (KZR) IPO Opens 33% Higher
-
William Blair Remains Bullish on Twilio (TWLO) Following Investor Meeting
-
Kezar Life Sciences, Inc. (KZR) Prices 5M Share IPO at $15/Sh
-
Kezar Life Sciences Announces Pricing of Initial Public Offering
-
Cushman & Wakefield Files Registration Statement for Proposed Initial Public Offering
-
UPDATE: Cushman & Wakefield Files IPO
-
William Blair Assumes Fitbit (FIT) at Market Perform
-
William Blair Starts Castlight Health Inc. (CSLT) at Outperform
-
William Blair Downgrades Foundation Medicine (FMI) to Market Perform Following Takeover
-
William Blair Downgrades Cotiviti Holdings (COTV) to Market Perform Following Acquisition
-
Veritas Capital-backed Verscend Reports $4.9B Acquisition of Cotiviti Holdings, Inc. (COTV)
-
Veritas Capital-backed Verscend to Acquire Cotiviti for $4.9 Billion
-
EverBank Financial (EVER) Announces 3.125M Class A Share IPO Between $15-17/Sh
-
EverQuote Launches Initial Public Offering of Class A Common Stock
-
William Blair Reiterates Outperform on Finisar (FNSR) Following 4Q
-
William Blair Remains Bullish on Ringcentral, Inc. (RNG) Following Analyst Day
-
BrightView Announces Launch of its Initial Public Offering
-
William Blair Upgrades PTC Therapeutics (PTCT) to Outperform
-
William Blair Starts EVO Payments (EVOP) at Outperform
-
Cision (CISN) Prices 12M Share Secondary Offering at $15/Sh
-
Cision Ltd. Announces Pricing of Secondary Offering
-
Voce Comments on Natus’ Attempt to Present a Façade of Improved Governance
-
Scotts Miracle-Gro (SMG) Updates Financial Outlook for Fiscal 2018, Sees Record Consumer Purchase Activity in May
-
ScottsMiracle-Gro Announces Record Consumer Purchase Activity in May; Updates Financial Outlook for Fiscal 2018
-
ScottsMiracle-Gro Announces Record Consumer Purchase Activity in May; Updates Financial Outlook for Fiscal 2018
-
LHC Group to Present at William Blair 38th Annual Growth Stock Conference
-
RealPage to Participate in Upcoming Investor Conference
-
PRA Group to Present at the William Blair 38th Annual Growth Stock Conference
-
PRA Group to Present at the William Blair 38th Annual Growth Stock Conference
-
Viking Therapeutics Announces Closing of Public Offering of Common Stock
-
Altair Announces Closing of Follow-on Public Offering and Exercise of Underwriters' Option to Purchase Additional Shares
-
Altair Announces Closing of Follow-on Public Offering and Exercise of Underwriters' Option to Purchase Additional Shares
-
AGCO to Present at the William Blair 2018 Growth Stock Conference
-
Tivity Health to Present at the William Blair 38th Annual Growth Stock Conference
-
Sontag Advisory, LLC Announces the Appointment of Gail Harris to the Advisor Team
-
William Blair Downgrades Envision Healthcare (EVHC) to Market Perform
-
Global Payments to Participate in Upcoming Investor Conferences
-
Aspen Technology to Present at the William Blair Growth Stock Conference
-
Primo Water to Participate in the 38th Annual William Blair Growth Stock Conference
-
KKR to take Envision private for $5.57 billion in healthcare push
-
Dynavax to Present at the William Blair 38th Annual Growth Stock Conference
-
Carbon Black to Present at the William Blair Growth Stock Conference
-
Altair to Present at J.P. Morgan Conference
-
Carbon Black to Present at the William Blair Growth Stock Conference
-
Altair to Present at J.P. Morgan Conference
-
Zumiez Announces Participation in the William Blair 38th Annual Growth Stock Conference

